PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

683 Capital Management, LLC's Holding History (CIK: 0001404574)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 380,669 Value ($000) $33,248 Avg Close $81.85 Range $62.24 - $96.54
Q3 2025
Shares 407,500 Value ($000) $27,070 Avg Close $56.84 Range $49.38 - $68.26
Q2 2025
Shares 445,000 Value ($000) $24,595 Avg Close $47.99 Range $39.60 - $57.70
Q1 2025
Shares 500,000 Value ($000) $24,180 Avg Close $41.90 Range $33.70 - $60.60
Q4 2024
Shares 410,000 Value ($000) $15,826 Avg Close $43.60 Range $33.31 - $48.89
Q3 2024
Shares 420,000 Value ($000) $18,900 Avg Close $40.40 Range $32.50 - $48.00
Q2 2024
Shares 604,449 Value ($000) $20,944 Avg Close $29.29 Range $24.22 - $35.96
Q1 2024
Shares 700,000 Value ($000) $20,251 Avg Close $27.21 Range $21.43 - $33.34
Q4 2023
Shares 715,000 Value ($000) $16,395 Avg Close $17.50 Range $13.72 - $23.88
Q3 2023
Shares 732,784 Value ($000) $12,223 Avg Close $19.40 Range $16.33 - $26.81
Q2 2023
Shares 814,000 Value ($000) $22,483 Avg Close $25.03 Range $17.64 - $30.10
Q1 2023
Shares 791,000 Value ($000) $18,193 Avg Close $16.79 Range $10.62 - $25.69
Q4 2022
Shares 207,800 Value ($000) $2,267 Avg Close $8.44 Range $7.24 - $11.46